Role of anti-obesity drugs in heart failure regardless of ejection fraction

被引：2
作者：
Butler, Javed [1 ,2 ]
Arshad, Muhammad Sameer [3 ]
Khan, Muhammad Shahzeb [4 ]
机构：
[1] Baylor Scott & White Res Inst, 3434 Live Oak St,Ste 501, Dallas, TX 75204 USA
[2] Univ Mississippi, Dept Med, Med Ctr, Jackson, MS USA
[3] Dow Univ Hlth Sci, Dow Med Coll, Dept Med, Karachi, Pakistan
[4] Duke Univ, Div Cardiol, Sch Med, Durham, NC USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷 / 08期
关键词：
OBESITY;
D O I：
10.1002/ejhf.3224
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1703 / 1706
页数：4
相关论文
共 15 条
[1]   Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets [J].
Borlaug, Barry A. ;
Jensen, Michael D. ;
Kitzman, Dalane W. ;
Lam, Carolyn S. P. ;
Obokata, Masaru ;
Rider, Oliver J. .
CARDIOVASCULAR RESEARCH, 2023, 118 (18) :3434-3450
[2]   Pericardiotomy Enhances Left Ventricular Diastolic Reserve With Volume Loading in Humans Implications for the Surgical Management of Heart Failure With Preserved Ejection Fraction [J].
Borlaug, Barry A. ;
Schaff, Hartzell V. ;
Pochettino, Alberto ;
Pedrotty, Dawn M. ;
Asirvatham, Samuel J. ;
Abel, Martin D. ;
Carter, Rickey E. ;
Mauermann, William J. .
CIRCULATION, 2018, 138 (20) :2295-2297
[3]   Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox [J].
Butt, Jawad H. ;
Petrie, Mark C. ;
Jhund, Pardeep S. ;
Sattar, Naveed ;
Desai, Akshay S. ;
Kober, Lars ;
Rouleau, Jean L. ;
Swedberg, Karl ;
Zile, Michael R. ;
Solomon, Scott D. ;
Packer, Milton ;
McMurray, John J., V .
EUROPEAN HEART JOURNAL, 2023, 44 (13) :1136-+
[4]   OBESITY AND CARDIAC-FUNCTION [J].
DEDIVITIIS, O ;
FAZIO, S ;
PETITTO, M ;
MADDALENA, G ;
CONTALDO, F ;
MANCINI, M .
CIRCULATION, 1981, 64 (03) :477-482
[5]   Obesity and Survival With Heart Failure Still a Paradox [J].
defilippi, Christopher R. ;
Seliger, Stephen L. .
JACC-HEART FAILURE, 2017, 5 (01) :64-66
[6]   Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes [J].
Heuvelman, Valerie D. ;
Van Raalte, Daniel H. ;
Smits, Mark M. .
CARDIOVASCULAR RESEARCH, 2020, 116 (05) :916-930
[7]   Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial [J].
Jorsal, Anders ;
Kistorp, Caroline ;
Holmager, Pernille ;
Tougaard, Rasmus Stilling ;
Nielsen, Roni ;
Hanselmann, Anja ;
Nilsson, Brian ;
Moller, Jacob Eifer ;
Hjort, Jakob ;
Rasmussen, Jon ;
Boesgaard, Trine Wellov ;
Schou, Morten ;
Videbaek, Lars ;
Gustafsson, Ida ;
Flyvbjerg, Allan ;
Wiggers, Henrik ;
Tarnow, Lise .
EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (01) :69-77
[8]   Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure The Need for Further Evidence Generation and Practice Guidelines Optimization [J].
Khan, Muhammad Shahzeb ;
Fonarow, Gregg C. ;
McGuire, Darren K. ;
Hernandez, Adrian F. ;
Vaduganathan, Muthiah ;
Rosenstock, Julio ;
Handelsman, Yehuda ;
Verma, Subodh ;
Anker, Stefan D. ;
McMurray, John J. V. ;
Kosiborod, Mikhail N. ;
Butler, Javed .
CIRCULATION, 2020, 142 (12) :1205-1218
[9]   Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity [J].
Kosiborod, Mikhail N. ;
Abildstrom, Steen Z. ;
Borlaug, Barry A. ;
Butler, Javed ;
Rasmussen, Soren ;
Davies, Melanie ;
Hovingh, G. Kees ;
Kitzman, Dalane W. ;
Lindegaard, Marie L. ;
Moller, Daniel V. ;
Shah, Sanjiv J. ;
Treppendahl, Marianne B. ;
Verma, Subodh ;
Abhayaratna, Walter ;
Ahmed, Fozia Z. ;
Chopra, Vijay ;
Ezekowitz, Justin ;
Fu, Michael ;
Ito, Hiroshi ;
Lelonek, Malgorzata ;
Melenovsky, Vojtech ;
Merkely, Bela ;
Nunez, Julio ;
Perna, Eduardo ;
Schou, Morten ;
Senni, Michele ;
Sharma, Kavita ;
Van der Meer, Peter ;
von Lewinski, Dirk ;
Wolf, Dennis ;
Petrie, Mark C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (12) :1069-1084
[10]   Human epicardial adipose tissue is a source of inflammatory mediators [J].
Mazurek, T ;
Zhang, LF ;
Zalewski, A ;
Mannion, JD ;
Diehl, JT ;
Arafat, H ;
Sarov-Blat, L ;
O'Brien, S ;
Keiper, EA ;
Johnson, AG ;
Martin, J ;
Goldstein, BJ ;
Shi, Y .
CIRCULATION, 2003, 108 (20) :2460-2466
12